Dzid XP 500mg/62.5mg Injection
Marketer
Dr. D Pharma
Salt Composition
Ceftazidime (500mg) + Tazobactum (62.5mg)
Overview Dzid XP 500mg/62.5mg Injection
Xylo-Comb 500mg/62.5mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administer this injection only under medical guidance; strictly adhere to the prescribed dosage schedule. Complete the entire course, even with symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms immediately. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration promote faster recovery. Your physician may order lab tests to monitor treatment response.
Uses of Dzid XP 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Dzid XP 500mg/62.5mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Dzid XP 500mg/62.5mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Dzid XP 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Dzid XP 500mg/62.5mg Injection works:
Dzid XP Injection, containing 500mg Ceftazidime and 62.5mg Tazobactum, combines an antibiotic with a resistance modifier. Ceftazidime's antibacterial action disrupts bacterial cell wall synthesis, hindering their growth. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial defenses, thereby improving Ceftazidime's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Dzid XP 500mg/62.5mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Dzid XP 500mg/62.5mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, data from human clinical trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Dzid XP (500mg/62.5mg) presents minimal risk to breastfeeding mothers. Research in humans indicates negligible transfer of the drug into breast milk, posing no discernible threat to the infant.
DrivingUNSAFE
The administration of Dzid XP 500mg/62.5mg Injection can potentially reduce vigilance, impair visual acuity, and induce drowsiness or vertigo. Driving should be avoided if such effects manifest.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Dzid XP 500mg/62.5mg Injection, as dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use the 500mg/62.5mg Dzid XP Injection cautiously; dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Dzid XP 500mg/62.5mg Injection :
Omitting a scheduled Dzid XP 500mg/62.5mg Injection requires immediate physician consultation.
Facts to Know About Dzid XP 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently